Astrocytes have important roles in disease and are difficult to modulate, owing to a paucity of known targets. Clayton et al. develop a screening platform to unbiasedly identify modulators of astrocyte reactivity. They discover that HDAC3 inhibitors regulate astrocyte transitions into their reactive phenotype in vitro and in vivo.
This is a preview of subscription content, log in via an institution to check access.
References
Allen, N. J. & Eroglu, C. Neuron 96, 697–708 (2017).
Lee, H. G., Lee, J. H., Flausino, L. E. & Quintana, F. J. Sci. Transl. Med. 15, eadi7828 (2023).
Liddelow, S. A. et al. Nature 541, 481–487 (2017).
Chai, H. et al. Neuron 95, 531–549.e9 (2017).
Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D. & Liddelow, S. A. Nat. Neurosci. 24, 1475–1487 (2021).
Guttenplan, K. A. et al. Nature 599, 102–107 (2021).
Clayton, B. L. L. et al. Nat. Neurosci. https://doi.org/10.1038/s41593-024-01580-z (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.L. declares ownership of AstronauTx Ltd. F.L. declares no competing interests.
Rights and permissions
About this article
Cite this article
Limone, F., Liddelow, S. The silence of the reactive astrocytes. Nat Neurosci 27, 607–609 (2024). https://doi.org/10.1038/s41593-024-01593-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-024-01593-8
- Springer Nature America, Inc.